HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Natsume Selected Research

A Natsume Research Topics

Disease

9Glioma (Gliomas)
10/2017 - 04/2000
7Neoplasms (Cancer)
10/2017 - 11/2001
2Glioblastoma (Glioblastoma Multiforme)
10/2015 - 04/2006
2Medulloblastoma
11/2012 - 08/2007
1Lung Neoplasms (Lung Cancer)
11/2012
1Astrocytoma (Pilocytic Astrocytoma)
04/2006
1Brain Neoplasms (Brain Tumor)
11/2001
1Residual Neoplasm
04/2000

Drug/Important Bio-Agent (IBA)

4Liposomes (Liposome)IBA
11/2010 - 04/2000
3Flucytosine (Ancobon)FDA Link
11/2012 - 08/2007
2ProdrugsIBA
11/2012 - 05/2010
2Cytosine DeaminaseIBA
11/2012 - 05/2010
2Proteins (Proteins, Gene)FDA Link
11/2010 - 04/2006
2Interferon-betaIBA
05/2010 - 04/2000
1Long Noncoding RNAIBA
10/2017
1epidermal growth factor receptor VIIIIBA
10/2015
1ErbB Receptors (EGF Receptor)IBA
10/2015
1Small Interfering RNA (siRNA)IBA
11/2010
1Alkylating AgentsIBA
11/2010
1DNA (Deoxyribonucleic Acid)IBA
11/2010
1Temozolomide (Temodar)FDA LinkGeneric
11/2010
1MethyltransferasesIBA
11/2010
1Therapeutic UsesIBA
11/2010
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2006
1Messenger RNA (mRNA)IBA
04/2006
1Angiogenesis InhibitorsIBA
04/2006
11,2-dilauroylphosphatidylcholineIBA
11/2001
1didodecyl N- (alpha- trimethylammonioacetyl)glutamateIBA
11/2001
1dioleoyl phosphatidylethanolamineIBA
11/2001
1Unilamellar LiposomesIBA
11/2001
1trioctyl phosphine oxide (TOPO)IBA
08/2000
1Type II DNA Topoisomerases (Topoisomerase II)IBA
08/2000
1Antineoplastic Agents (Antineoplastics)IBA
08/2000
1Etoposide (VP 16)FDA LinkGeneric
08/2000

Therapy/Procedure

1Aftercare (After-Treatment)
11/2012
1Drug Therapy (Chemotherapy)
11/2010
1Radiotherapy
11/2010
1Therapeutics
11/2010
1Immunotherapy
11/2001